$0.515
-0.024 (-4.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PMCB Prediction & Forecast by Similar Chart Analysis
Alphio's PMCB stock price prediction model matches the current PharmaCyte Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.52 (+0.35%). The 1-week path is $0.51 (-1.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy PharmaCyte Biotech Inc Stock?
PharmaCyte Biotech Inc is not a good buy right now due to its declining performance and negative financial metrics. The current price is $0.515, and the stock has seen a 30.22% decline year-to-date. Additionally, the RSI is at 31.15, indicating that the stock is oversold, but this does not necessarily imply a buying opportunity given the overall negative trend.
PMCB stock price ended at $0.52 on Friday, after losing -4.66%
PharmaCyte Biotech Inc (PMCB) last closed at $0.515, losing -4.66%. These facts feed the 1-day and 1-week PMCB price prediction above.
Forecast Drivers
PharmaCyte Biotech Inc (PMCB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PMCB, ranked by similarity.
Seasonality analysis for PMCB
Historically the probability of a positive August return for PMCB is 0.00%. January offers the highest probability of a positive month at 60.66%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PMCB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.85 | $0.98 | $1.15 | +90.27% |
| Sep 2026 | $0.86 | $0.92 | $1.01 | +78.50% |
| Oct 2026 | $0.94 | $1.12 | $1.19 | +117.01% |
| Nov 2026 | $1.07 | $1.07 | $1.11 | +108.15% |
| Dec 2026 | $0.86 | $0.95 | $0.97 | +83.56% |
In 2026, PharmaCyte Biotech Inc (PMCB) is projected to range from $0.85 to $1.19.
PharmaCyte Biotech Inc 2026 monthly forecast
In Aug 2026, PharmaCyte Biotech Inc is projected to average $0.98, with a low of $0.85 and high of $1.15.
In Sep 2026, PharmaCyte Biotech Inc is projected to average $0.92, with a low of $0.86 and high of $1.01.
In Oct 2026, PharmaCyte Biotech Inc is projected to average $1.12, with a low of $0.94 and high of $1.19.
In Nov 2026, PharmaCyte Biotech Inc is projected to average $1.07, with a low of $1.07 and high of $1.11.
In Dec 2026, PharmaCyte Biotech Inc is projected to average $0.95, with a low of $0.86 and high of $0.97.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.